anmelden
OMX Nordic 40
2.711,69
PKT
-3,84
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.06.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 04.06.20 | AstraZeneca Sell | UBS AG | |
| 02.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.06.20 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 01.06.20 | Nokia overweight | JP Morgan Chase & Co. | |
| 29.05.20 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 28.05.20 | A.P. Moeller - Maersk A-S (B) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.20 | AstraZeneca Sell | UBS AG | |
| 26.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Jefferies & Company Inc. | |
| 25.05.20 | AstraZeneca Sell | UBS AG | |
| 22.05.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 22.05.20 | AstraZeneca Sell | UBS AG | |
| 21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital | |
| 20.05.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 18.05.20 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.05.20 | Novo Nordisk Neutral | UBS AG | |
| 14.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 14.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 13.05.20 | A.P. Moeller - Maersk A-S (B) neutral | Goldman Sachs Group Inc. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.05.20 | Hennes Mauritz (H M, H&M) Equal-Weight | Morgan Stanley | |
| 12.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 12.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Kepler Cheuvreux | |
| 11.05.20 | Novo Nordisk Neutral | UBS AG | |
| 11.05.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 07.05.20 | Novo Nordisk overweight | Barclays Capital | |
| 07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.05.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 06.05.20 | Novo Nordisk buy | UBS AG | |
| 06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
